Neko Health SE
Longevity & preventionPreventive full-body scanning with continuous follow-up. Series C of US$ 700M at ~US$ 7B valuation.
TechCrunchJul 2026Confidence: A — primary source, public method, under 18 months old
Eight recent, public transactions — one or more per vertical — that show where demand and capital are moving. They illustrate the thesis; they are not our portfolio.
Market signals, not portfolio. Public examples of capital and demand in our verticals, each with source and date. None is a portfolio company, target or partner.
Preventive full-body scanning with continuous follow-up. Series C of US$ 700M at ~US$ 7B valuation.
TechCrunchJul 2026Confidence: A — primary source, public method, under 18 months old
160+ lab tests by subscription; acquired Ezra (whole-body MRI). Series B of US$ 298M at US$ 2.5B.
TechCrunchNov 2025Confidence: A — primary source, public method, under 18 months old
Home lab tests and vaccines, profitable. Raised R$ 100M at R$ 1.2B valuation (Lightsmith, CZI).
NeoFeedSep 2024Confidence: A — primary source, public method, under 18 months old
Full-stack psychiatry. Series D of US$ 210M (Perceptive, Sofina, a16z).
Behavioral Health BusinessFeb 2026Confidence: A — primary source, public method, under 18 months old
Brazilian-born corporate wellbeing platform acquires Urban Sports Club for ~US$ 600M.
AxiosSep 2025Confidence: A — primary source, public method, under 18 months old
Medical longevity resorts. €95M for ~20% from King Street Capital and AltamarCAM.
BloombergOct 2025Confidence: A — primary source, public method, under 18 months old
Smart ring for sleep and recovery; 5.5M+ rings sold. Series E of US$ 900M+ at US$ 11B.
CNBCOct 2025Confidence: A — primary source, public method, under 18 months old
Smart ring with integrated glucose monitoring; ~US$ 140M ARR. US$ 70M round backed by Qualcomm Ventures and Labcorp.
TechCrunchSep 2026Confidence: A — primary source, public method, under 18 months old
No matches for this filter yet.